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Erythropoietic protoporphyria is a genetic disease caused by the accumulation of protopor-
phyrin IX. This molecule absorbs 400-nm light and its presence is at times associated with 
severe cutaneous photosensitivity. The only effective treatment for this disease is oral 
administration of beta carotene. 
Several possible mechanisms of photo protection by beta carotene were investigated using 
the photohemolysis of red blood cells as an in vitro model. Additional studies were done in an 
in vivo model which involves lethal hematoporphyrin photosensitization of white mice. The 
photoprotective effects of beta carotene were compared with those of alpha tocopherol, an 
agent which possesses some but not all the properties that have been implicated in explain-
ing the known effectiveness of beta carotene. In the photohemolysis model, both compounds 
demonstrated partial protection. In hematoporphyrin-photosensitized mice, tocopherol 
showed some protection at high doses, while beta carotene showed greater protection at 
lower concentrations. 
Although these results suggest that photoprotection was due to free radical scavenging or 
singlet oxygen quenching, properties common to both agents, they do not rule out the 
possible role of 400-nm light absorption, a property of beta carotene alone. 
Erythropoietic protoporphyria \EPP) is a domi-
nantly inherited defect in porphyrin metabolism 
resulting in the accumulation of protoporphyrin 
IX 11 ,2], a water-insoluble porphyrin demonstra-
ble in the patients' erythrocytes that strongly ab-
sorbs light of wavelength 400 nm. Clinically, these 
patients have severe photosensitivity character-
ized by marked burning, pruritus, and edema fol-
lowing brief exposure to intense 400-nrn light ll-
3]. Avoidance is very difficult and most topical 
preparations are of little value in protecting pa-
tients with EPP, but oral beta carotene has proved 
very effective. 
Several mechanisms for this protection have 
been postulated. Beta carotene strongly absorbs 
400-nm light, and simple absorption of light by 
beta carotene in the stratum corneum may pre-
vent penetration and symptoms. Porphyrin-in-
duced photosens itivity in laboratory models is an 
oxygen-dependent process 14- 6) involving an ex-
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cited singlet oxygen intermediate l7]. Free radi-
cals are generated following photoexcitation of 
various porphyrin derivatives in vitro 18-11]. Beta 
carotene is very efficient in trapping singlet ex-
cited oxygen and quenching free radicals [7.12]. 
Either of these properties may explain beta caro-
tene's efficacy. Finally, beta carotene may act in 
some undefined way to prevent or repair the pho-
totoxic damage. Alpha tocopherol also traps free 
radicals and quenches singlet oxygen [13], but 
does not absorb 400-nm light. Alpha tocopherol 
and beta carotene were studied and compared us-
ing in vivo and in vitro techniques previously 
described [5,6,9,14-20] in an attempt to evaluate 
the mechanisms involved in photoprotection. 
MA TERlALS AND METHODS 
Photohemolysis Studies 
Protection against. in vitro photohemolysis of red 
cells from patients with EPP, and of normal red cells 
photosensitized with hematoporphyrin was st.udied, us-
ing techniques previously described, with minor modi-
fications ]15.16.21 ]. 
Preparation of erythrocytes. A hexane solution of al-
pha tocopherol (1.5 mg) or beta carotene (0.5 mg) was 
evaporated to dryness with nitrogen in a 25-ml Erlen-
meyer flask. Five milliliters of whole blood was added 
to the flask and incubated for 6 to 12 hr in a water bath 
at 37°C with constant shaking. After incubation, red 
blood cell CRBC) concentrations of alpha tocopherol and 
beta carotene ranged from 20 to 60 and 0.2 to 0.8 J.Lg/ml 
of packed RBC, respectively. The analytical procedures 
for these determinations are described elsewhere 122J. 
Control erythrocytes were incubated identically, but in 
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the a bsence of the protective agent. All cells were then 
washed 3 times in normal saline, and suspended at a 
1:800 dilution in either isotonic phosphate-buffered sa-
line, pH 7.4 <EPP cells), or in identical buffered solution 
to which 0. 1 mg% hematoporphyrin had been added 
(normal cells). 
Photoprotection assay. Three milliliters of the RBC 
suspensions were placed in a 3-ml quartz cuvette 2.5 em 
in diameter with an optical pathway of 1 em. The cu-
vettes were then exposed to 400-nm radiation from a 
bank of 3 General Electric 20-watt bluelight fluorescent 
tubes (spectral range 380-520 run) at a distance of 10 em 
(output 696 J.LW/cm2) for various time periods. Hemoly-
sis was determined by means of direct cell counts in a 
hemocytometer before, during, and after irradiation. 
Additional control samples were kept in the dark, and 
hemolysis determined at the conclusion of each photo-
hemolysis experiment. 
Animal Studies 
Hematoporphyrin phototoxicity in mice. The approxi-
mate dose of hematoporphyrin intraper itoneally ad-
ministered required to kill half the exposed animals 24 
hr after exposure (LD;,,/1 day) was determined as de-
scribed previously !21], except that 2 hr of bluelight 
fluorescent tube (see above) exposure replaced the 
blacklight fluorescent tubes. 
Toxicity studies of alpha tocopherol and beta carotene. 
Using identical exposure conditions (2 hr bluelight at 
10 em) mice were exposed 24 hr after the intraperitoneal 
administration of either agent in various dosages ad-
justed to maintain the total intraperitoneal volume at 
or below 1 mi. No toxicity was observed at any of the 
dosages used. 
Photoprotection studies using beta carotene and alpha 
tocopherol. Two hundred and thirteen mice were irradi-
ated in groups as summarized in the Table. Fifty-nine 
animals received beta carotene, 0.2 mg/gm body weight 
in Emulfor intraperitoneally 24 hr prior to irradiation, 
and hematoporphyrin. 0.1 mg/gm intra peritoneally, 30 
min before irradiation. Fifty animals received alpha 
tocopherol. 1 mg/gm in Emulfor intraperitoneally <high 
dose) 24 hr prior to irradiation, and hematoporphyrin. 
0.1 mg/gm intraperitoneally 30 min before irradiation. 
Thirty animals received alpha tocopherol. 0.5 mg/gm in 
Emulfor intraperitoneally tlow dose) 24 hr prior to irra-
diation, and hematoporphyrin. 0.1 mg/gm intraperi to-
neally 30 min before irradiation. In all animals, the 
total volume injected intraperitoneally 24 hr before ir-
radiation was approximately 0.5 ml. Seventy-four ani-
mals served as controls and received the vehicle, Ernul-
for alone, 0.5 ml intraperitoneally 24 hr before irradia-
tion, and hematoporphyrin, 0.1 mg/gm 30 min before 
TABLE. Photoprotectiue effects of intraperitoneal 
administration of alpha tocopherol and beta carotene in 
hematoporphyrin-photosensitized mice after 2 hr of light 
exposure 
Experi- Control" 
Photoprotective agent mental 
# % # % 
Tocopherol (1 mg/gm)1' 18/50 36 11/50 22 o/C 
Tocopherol (0.5 mg/gmJ 10/30 33 9/24 38 
Carotene (0.2 mg/gm)'' 32/59 54 15/54 28 
a Control animal received only Emulfor vehicle and 
hematoporphyrin. 
b Significant at 0.05 > p > 0.025 level by chi square. 
' Significant at 0.005 > p level by chi square. 
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irradiation. All animals were exposed to light in groups 
of 5 or 6 on successive days, and in each case at least one 
group of control animals was exposed simultaneously 
with the experimental groups. No anesthesia was re-
quired during either the intraperitoneal administration 
of the various agents or during the exposure to blue-
light. During the light exposure, the animals were 
individually restrained under half-inch wire mesh 
holders. Viability was assessed after 24 and 48 hr. 
RESULTS 
Photohemolysis 
The results of various photohemolysis experi-
ments, using both normal red cells photosensitized 
with hematoporphyrin and red cells from patients 
with EPP, are summarized in Figures 1-4. These 
results are expressed as percent hemolysis per 
unit time. The hemolysis was determined by direct 
cell counts. The time course of hemolysis of the 
controls was adjusted by varying the total irradia-
tion time so that the hemolysis could be conven-
iently observed. Control studies, using cells 
treated in a manner identical to the experimental 
groups but without irradiation, showed no signifi-
cant hemolysis. Similarly , normal cells, in the 
absence ofhematoporphyrin but in the presence of 
beta carotene or alpha tocopherol and irradiation, 
showed negligible hemolysis. As noted in Figure 1, 
the protection afforded by beta carotene against 
photohemolysis was demonstrated by the prolon-
gation of t he time required for 100% hemolysis of 
the red cells from 20 to 24 hr. No signif1cant hemol-
ysis was observed during the first 10 hr in either 
the experimental or control red cells. As shown in 
Figure 2, essentially the same data were obtained 
when alpha tocopherol was used as the protective 
agent. In Figures 3 and 4, when the dose of radia-
tion was increased by lengthening the exposure 
time from 20 min io 1 hr, complete hemolysis was 
noted in less than 8 hr. In both studies, the alpha 
tocopherol-treated cells were protected, as indi-
cated by the prolongation of the time required for 
complete hemolysis. 
Animal Studies 
The resuJts of the photoprotection studies in 
mice are summarized in the Table and Figure 5. 
Survival in control animals, given only hemato-
porphyr in and Emulfor 1 day after exposure to 
100 Control/ 
II / Aarotono 
75 
II 
ll'--~18----~19----~2.----~2~1----2~2 ----2)----~2~ 
HOURS 
Pre. 1. Photoprot.ection by beta carotene against pho-
tohemolysis of EPP red cells. Summary of 3 experi-
ments each using at least 6 groups. Data obtained by 
direct cell counts. Cells exposed to light for 20 min. 
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FIG. 2. Photoprotection by alpha tocopherol against 
photohemolysis of EPP red cells. Summary of 4 experi-
ments each using at least 6 exeerimental groups. Data 
obtained by direct cell counts. Cells exposed to light for 
20 min. 
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FIG. 3. Photoprotection by alpha tocopherol against 
photo hemolysis of EPP red cells. Summary of 4 exper i-
ments each using at least 6 groups. Data obtained by 
direct cell counts. Exposed to light for 1 hr. 
bluelight, ranged from 22 to 38%- of the animals. 
Beta carotene showed the best protection (54t.k- vs 
27o/c) at a dose !0.2 mglgm) that was significantly 
lower than either a lpha tocopherol dose tested. 
Low doses !0.5 mg/gml of alpha tocopherol showed 
no photoproteclion f33o/c) . High doses (1 mg/gml, 
however, showed some protection (36%- vs 22o/cl. 
There is an apparent discrepancy in the number of 
control animals as listed in the Table and F igure 5 
and as stated in Materials and Methods. This 
resulted from the processing of several experimen-
tal groups simuhaneou sly with a single control 
group. Thus, the same animals may have served 
as con trols for several but not all exper iments. 
Animals were tabulated as controls only when 
processed simultaneously with the corresponding 
exper imental animals. The solubilizer (Emulfor) 
a lone h ad no protective effect. In the absence of 
hematoporphyrin, none of the animals succumbed. 
Similarly, in the absence of exposure to 400-nm 
light, no animals succumbed. 
DISCUSSION 
Previous investiga tions have demonstrated the 
value of red blood cells from EPP patients and 
photosensitized normal red cells in the study of the 
mechanism of cell membrane damage from 400-nm 
radiation 14,8,14,16- 18,20.23). This photohemol-
ysis is oxygen dependent 14-6], associated with 
free radical l8-11) and peroxide !6,8,24) formation, 
and the observed cell destruction is due to colloid 
osmotic hemolysis 114,17] initiated by the forma-
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tion of holes in the cell membrane under 10 A in 
size 117.1. 
The red cell photoprotective agents discovered 
in the studies have infrequently been tested in 
animal experimen ts. A recent report by Harber et 
aJ 121) demonstrated that ruthiothreitol and glyc-
erol act synergistically to protect hematopor-
phyrin-photosensitized mice and inhibit the photo-
hemolysis of red cells. In addition. beta carotene 
was shmvn to protect hematoprophyrin-photosen-
sitized mice prior to its very successful use in 
pa tients with EPP 125]. 
In the present study, we were able to evaluate 
and compare beta carotene and alpha tocopherol 
not only in vitro in red cell photohemolysis, but 
also in hematoporphyr in-photosensitized mice 
studies. 
Beta carotene contains 11 conjugated double 
bonds, and shows significant absorption at 400 run. 
It is an active free radical t rap and singlet excited 
oxygen quencher 112]. Here and in previously pre-
sented data, beta carotene has been demonstrated 
to be effective in preventing t he deleterious effects 
of porphyrin derivatives plus 400-nm ligh t in red 
cell photohemolysis models, photosensitized labo-
ratory animals, and EPP patients [14,19,25). Al-
pha tocopherol contains only 3 conjugated double 
bonds, does not absorb 400-nm light (it has no 
significant absorption above 310 nml, less avidly 
quenches singlet excited oxygen, but is an even 
more active free radical trap t han is beta carotene 
(A. A. Lamola, personal communication) 113]. 
The similarity in the results of the photohemol-
ysis experiments using beta carotene and alpha 
F1a. 4. Photoprotection by alpha tocopherol against 
photohemolysis of hematoporphyrin-photosensitized 
red cells. Summary of 4 experiments each using 6 
groups. Data obtained by direct cell counts. Cells ex-
posed to light for 1 hr. 
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.F~a. 5. _Photoprotective effects of intraperitoneal ad-
m1mstrat10n of alpha tocopherol and beta carotene in 
hematoporphyrin-photosensitized mice after 2 hr of 
light exposure. 
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tocopherol as protective agents would suggest that 
free radicals do take part in the reaction and that 
quenching these free radicals can inhibit mem-
brane damage [21). These results also suggest that 
photon absorption of 400-nm light is not the only 
mechanism by which beta carotene may exert a 
protective effect. 
The animal experiments demonstrate beta caro-
tene to be a more effective photoprotective agent 
than alpha tocopherol. This implies that free radi-
cal scavenging is not the only mechanism of beta 
carotene's photoprotection, for were this the case, 
one would expect alpha tocopherol, the more avid 
free radical scavenger, to be superior . However, 
there are several other possible explanations for 
this result. In this animal model, the tested agents 
were administered intraperitoneally. Active drug 
must reach the site of photo toxic damage in order 
to be protective. Major differences in absorption, 
distribution. or metabolism could alter the concen-
tration of active drug at this site. overshadowing 
any differences in free radical scavenging or sin-
glet oxygen quenching. Some observations as to 
the differences in transport and storage of these 
two agents in man appears in another report by 
our group l22]. 
The available data are insufficient to comment 
on the effect of drug localization on photoprotec-
tion, although the drug must be in close proximity 
to any short-lived free radicals or excited singlet 
oxygen generated in the phototoxic reaction in 
order to prevent irreversible damage. Simple ab-
sorption of 400-nm light by beta carotene seems an 
unlikely explanation for the prime mechanism of 
photoprotection, as the patients are ra rely grossly 
carotenemic at doses that prove protective, and 
topical application is totally ineffective as it is 
rapidly bleached upon exposure to intense light 
l25]. Thus, it seems likely that both free radical 
trapping and singlet excited oxygen quenching are 
involved in beta carotene's photoprotection in 
EPP, a lthough the relative importance of these 
two properties cannot be evaluated at present, and 
the simple absorption of 400-nm light. a lthough 
unlikely, cannot be ruled out. 
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